Fluid biomarkers in multiple system atrophy: A review of the MSA Biomarker Initiative-Reference-Cited by-同舟云学术

Fluid biomarkers in multiple system atrophy: A review of the MSA Biomarker Initiative

Published:2015-08 Issue: Volume:80 Page:29-41
ISSN:0969-9961
Container-title:Neurobiology of Disease
language:en
Short-container-title:Neurobiology of Disease

Author:

Laurens Brice,Constantinescu Radu,Freeman Roy,Gerhard Alexander,Jellinger Kurt,Jeromin Andreas,Krismer Florian,Mollenhauer Brit,Schlossmacher Michael G.,Shaw Leslie M.,Verbeek Marcel M.,Wenning Gregor K.,Winge Kristian,Zhang Jing,Meissner Wassilios G.

Publisher

Elsevier BV

Subject

Neurology

Reference105 articles.

1. Cerebrospinal fluid analysis differentiates multiple system atrophy from Parkinson's disease;Abdo;Mov. Disord.,2004

2. CSF neurofilament light chain and tau differentiate multiple system atrophy from Parkinson's disease;Abdo;Neurobiol. Aging,2007

3. CSF biomarker profiles do not differentiate between the cerebellar and parkinsonian phenotypes of multiple system atrophy;Abdo;Parkinsonism Relat. Disord.,2007

4. CSF hypocretin-1 levels are normal in multiple-system atrophy;Abdo;Parkinsonism Relat. Disord.,2008

5. CSF alpha-synuclein does not differentiate between parkinsonian disorders;Aerts;Neurobiol. Aging,2012

Cited by 64 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The potential of phosphorylated α‐synuclein as a biomarker for the diagnosis and monitoring of multiple system atrophy;CNS Neuroscience & Therapeutics;2024-04

2. Multiple system atrophy: Clinical, evolutive and histopathological characteristics of a series of cases;Neurología (English Edition);2023-11

3. Diagnosing multiple system atrophy: current clinical guidance and emerging molecular biomarkers;Frontiers in Neurology;2023-09-29

4. α-Synuclein-carrying astrocytic extracellular vesicles in Parkinson pathogenesis and diagnosis;Translational Neurodegeneration;2023-08-25

5. Multidimensional biomarkers for multiple system atrophy: an update and future directions;Translational Neurodegeneration;2023-07-28